Literature DB >> 15270615

Loss of heterozygosity patterns of sclerosing hemangioma of the lung and bronchioloalveolar carcinoma indicate a similar molecular pathogenesis.

Sanja Dacic1, Eizaburo Sasatomi, Patricia A Swalsky, Dong Won Kim, Sydney D Finkelstein, Samuel A Yousem.   

Abstract

CONTEXT: The histogenesis and origin of sclerosing hemangioma (SH) of lung were uncertain for many years. Many immunohistochemical, ultrastructural, and recent molecular studies support the hypothesis that SH is a neoplasm originating from the cells of the terminal lobular unit, similar to the nonmucinous variant of bronchioloalveolar carcinoma (BAC). Most cases of SH are benign, but they can metastasize to the regional lymph nodes.
OBJECTIVE: To compare the patterns of allelic loss of tumor suppressor genes in SH and BAC by microdissection-based genotypic analysis.
DESIGN: Microdissection-based loss of heterozygosity analysis of 9 cases of SH and 14 cases of BAC, using a panel of 7 polymorphic microsatellite markers located on 1p, 5q, 9p, 10q, and 17p. Microsatellite marker and chromosomal arm-based fractional allelic loss (FAL) were calculated in each case.
RESULTS: Our results showed similar patterns of allelic loss between the 2 groups of tumors on an individual case basis. Chromosomal arms 5q and 10q showed frequent allelic loss in SH (66.7% and 62.5%, respectively), whereas in BAC, chromosomal arm 17p (52.6%) was frequently affected. A statistically significant difference in allelic loss between SH and BAC was located only on chromosomal arm 5q (P =.04). Microsatellite marker D5S615 was significantly more frequently affected in SH than in BAC (66.7% vs 28.6%; P =.04).
CONCLUSION: Our molecular data support the hypothesis of common origin of SH and BAC. A putative tumor suppressor gene that might play a role in tumorigenesis of SH may be located on the chromosomal arm 5q.

Entities:  

Mesh:

Year:  2004        PMID: 15270615     DOI: 10.5858/2004-128-880-LOHPOS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  In pulmonary sclerosing hemangioma expression of β-catenin, Axin, and C-myc differs between the two cell types.

Authors:  Xu-Yong Lin; Di Zhang; Yong Zhang; Chui-Feng Fan; Shun-Dong Dai; En-Hua Wang
Journal:  Virchows Arch       Date:  2012-05-22       Impact factor: 4.064

2.  Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung.

Authors:  Seung-Hyun Jung; Min Sung Kim; Sung-Hak Lee; Hyun-Chun Park; Hyun Joo Choi; Leeso Maeng; Ki Ouk Min; Jeana Kim; Tae In Park; Ok Ran Shin; Tae-Jung Kim; Haidong Xu; Kyo Young Lee; Tae-Min Kim; Sang Yong Song; Charles Lee; Yeun-Jun Chung; Sug Hyung Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

3.  Determination of clonal status of pulmonary sclerosing hemangioma with X-chromosome inactivation mosaicism and polymorphism of phosphoglycerate kinase and androgen receptor genes.

Authors:  Li Gong; Kai-Xi Ren; Yan-Hong Li; Xiao-Yan Liu; Wen-Dong Zhang; Li Yao; Shao-Jun Zhu; Xiu-Juan Han; Li Zhang; Miao Lan; Wei Zhang
Journal:  Med Oncol       Date:  2010-04-27       Impact factor: 3.064

4.  Single nucleotide polymorphism profiling assay to confirm the identity of human tissues.

Authors:  Ronald Huijsmans; Jan Damen; Hans van der Linden; Mirjam Hermans
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

Review 5.  Lung cancer in never smokers.

Authors:  Ping Yang
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

6.  Correlation Between Pulmonary Sclerosing Pneumocytoma Features and MSCT Imaging Manifestations in 34 Patients: Implications for Precision Medicine.

Authors:  Gen Xu; Zhaoyu Wang; Zeng Xiong; Manqiu Li; Weijun Luo; Yong Xu; Tang Min
Journal:  Front Med (Lausanne)       Date:  2021-03-18

7.  [Analysis of Clinical Characteristics of 35 Cases 
of Pulmonary Sclerosing Pneumocytoma].

Authors:  Xiaojing Liu; Zhihao Huang; Jianyong Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-12-20

8.  Pulmonary sclerosing hemangioma presenting with dense spindle stroma cells: a potential diagnostic pitfall.

Authors:  Xu-Yong Lin; Yan Wang; Chui-Feng Fan; Yang Liu; Juan-Han Yu; Shun-Dong Dai; Liang Wang; En-Hua Wang
Journal:  Diagn Pathol       Date:  2012-12-10       Impact factor: 2.644

9.  Pulmonary sclerosing hemangioma: a unique epithelial neoplasm of the lung (report of 26 cases).

Authors:  Bojiang Chen; Jun Gao; Hong Chen; Yidan Cao; Xin He; Wen Zhang; Man Luo; Shangfu Zhang; Weimin Li
Journal:  World J Surg Oncol       Date:  2013-04-15       Impact factor: 2.754

10.  SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.

Authors:  Yin Peng; Xiaojing Zhang; Huijuan Lin; Shiqi Deng; Ying Qin; Yuan Yuan; Xianling Feng; Jian Wang; Wangchun Chen; Fan Hu; Ruibin Yan; Yanqiu Zhao; Yulan Cheng; Yanjie Wei; Xinmin Fan; Hassan Ashktorab; Duane Smoot; Song Li; Stephen J Meltzer; Zhe Jin
Journal:  Cell Cycle       Date:  2020-10-05       Impact factor: 4.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.